<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteAging &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/aging/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Ichor: Reversing Aging</title>
				<link>https://wyss.stage.a17.io/technology/ichor-reversing-aging/</link>
        <pubDate>Wed, 01 May 2024 10:47:33 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Cardiovascular Dysfunction]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[RNA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=35547</guid>
                                                <content:encoded><![CDATA[<p>More than 150,000 people die each day across the globe, about two&#x2d;thirds of them from age&#x2d;related causes like cancer, neurodegenerative diseases, and cardiovascular disease. If the process of aging could be slowed or reversed, the incidence of these conditions would be dramatically reduced, and more humans would live longer, healthier lives. However, aging is a complex process involving multiple&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/ichor-reversing-aging/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/ichor-reversing-aging/</link>
          <title>Immunofluorescent image demonstrating the multiple cell types that arise within the human bone marrow chip (magenta: erythroid cells, yellow: megakaryocytes, blue: other CD45+ hematopoietic cells). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2018/10/31093913/Bone-Marrow-on-a-Chip-image.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ba74541c94eecd3d790c2daec60bd1ed"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute&#8217;s 2023-2024 Validation Projects</title>
				<link>https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/</link>
        <pubDate>Thu, 19 Oct 2023 14:47:13 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37800</guid>
                            <description>13 projects selected to receive Validation Project support to advance commercialization and impact</description>
                                        <content:encoded><![CDATA[<p>Each year we name a class of Validation Projects whose teams receive dedicated funding, business development support, and additional resources to advance their technologies towards commercialization. Over the course of the year, project teams pursue initial use&#x2d;cases for their technologies that have the potential for significant positive impact. They also collaborate with key opinion leaders&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/07/31105458/HarborSite-Team-0469_Final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=be4985fe4121bd6050761dce0a53eb30"/></url>
				</image>
        			</item>

		
			<item>
				<title>Clearing a path for non-invasive muscle therapy for the elderly</title>
				<link>https://wyss.stage.a17.io/news/clearing-a-path-for-non-invasive-muscle-therapy-for-the-elderly/</link>
        <pubDate>Wed, 22 Mar 2023 17:57:17 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Bioinspired Soft Robotics]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Muscle]]></category>
		<category><![CDATA[Soft Robotics]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=36144</guid>
                            <description>Controlling inflammation enables injured aged muscle recovery via non-invasive mechanical loading, offering promise for the future of mechanotherapies for elderly patients</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Mechanotherapy, the concept of using mechanical forces to stimulate tissue healing, has been used for decades as a form of physical therapy to help heal injured muscles. However, the biological basis and optimal settings for mechanotherapies are still poorly understood, especially with respect to elderly patients. Given the well&#x2d;known decline in healing ability&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/clearing-a-path-for-non-invasive-muscle-therapy-for-the-elderly/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/clearing-a-path-for-non-invasive-muscle-therapy-for-the-elderly/</link>
          <title> In the future, massage guns like this could give way to wearable personalized robotic mechanotherapy devices to heal muscle injuries across all ages. As demonstrated in this study, these approaches will have to take into account differences in inflammation between younger and older muscles, and the likely need for co-delivering anti-inflammatory therapies in the elderly to achieve healing effects. Credit: Shutterstock/Andrey Popov</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/03/21095733/shutterstock_1993793792-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b433ea71f10477deb049530ed7d0af45"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagine the World: Volume 1</title>
				<link>https://wyss.stage.a17.io/media-post/reimagine-the-world-volume-1/</link>
        <pubDate>Thu, 22 Sep 2022 13:58:05 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Reimagine the World]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=33937</guid>
                                                <content:encoded><![CDATA[<p>Four Wyss Institute scientists, Mariana Garcia&#x2d;Corral, Pawan Jolly, Megan Sperry, and Mike Super, share how they would Reimagine the World and the personal stories that fuel their passion for the work they are doing. We&rsquo;d love to hear how you would Reimagine the World! Please visit the following link to share your ideas: https://wyss.typeform.com/to/o9xM7cG1 Credit: Wyss Institute at Harvard&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/reimagine-the-world-volume-1/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/reimagine-the-world-volume-1/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/09/22092550/THUMBNAIL_Reimagine-the-World_Volume-I_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=e28558bd8d562b1c670d9c83fc58f458"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagine the World</title>
				<link>https://wyss.stage.a17.io/news/reimagine-the-world/</link>
        <pubDate>Thu, 22 Sep 2022 13:20:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Reimagine the World]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=33890</guid>
                            <description>If you could reimagine the world, what would it look like?</description>
                                        <content:encoded><![CDATA[<p>Beginning in Fall 2022, we are asking our Wyss community &ndash; our Faculty, staff, collaborators, partners, and external supporters &ndash; &ldquo;If you could reimagine the world, what would it look like?&rdquo; Every day Wyss members work to reimagine a world where anything is possible. It&rsquo;s a world of scientific discovery, imagination, and reality, where diseases are cured, global warming is reversed&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/reimagine-the-world/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/reimagine-the-world/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/09/19152558/ReimageTheWorld-logo-on-black-e1663865026765.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=dd592415861efcf29bfd32650af7ae23"/></url>
				</image>
        			</item>

		
			<item>
				<title>Landing therapeutic genes safely in the human genome</title>
				<link>https://wyss.stage.a17.io/news/landing-therapeutic-genes-safely-in-the-human-genome/</link>
        <pubDate>Mon, 24 Jan 2022 15:57:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Skin]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=31381</guid>
                            <description>Researchers at Harvard’s Wyss Institute, Harvard Medical School, and the ETH Zurich predict and validate genomic safe harbors for therapeutic genes, enabling safer, more efficient, and predictable gene and cell therapies </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Many future gene and cell therapies to treat diseases like cancer, rare genetic and other conditions could be enhanced in their efficacy, persistence, and predictability by so&#x2d;called &ldquo;genomic safe harbors (GSHs).&rdquo; These are landing sites in the human genome able to safely accommodate new therapeutic genes without causing other, unintended changes in a cell&rsquo;s&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/landing-therapeutic-genes-safely-in-the-human-genome/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/landing-therapeutic-genes-safely-in-the-human-genome/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/01/21134525/Genomic-Safe-Harbor-illustration.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7f08e7c6a8c10ace1cde35a073e1d616"/></url>
				</image>
        			</item>

		
			<item>
				<title>Denitsa Milanova on MRBL – Gene Therapy for Skin Rejuvenation</title>
				<link>https://wyss.stage.a17.io/news/denitsa-milanova-on-mrbl-gene-therapy-for-skin-rejuvenation/</link>
        <pubDate>Thu, 25 Mar 2021 14:45:11 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=27929</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. When Denitsa Milanova was an engineering graduate student at Stanford University, she started taking business classes on the side to learn more about herself and her interests. She ended up with&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/denitsa-milanova-on-mrbl-gene-therapy-for-skin-rejuvenation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/denitsa-milanova-on-mrbl-gene-therapy-for-skin-rejuvenation/</link>
          <title>Denitsa Milanova, Technology Development Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/03/25102851/WoW-Purple-Denitsa-Milanova-9218-Uncolorcorrected.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=6875929280d0fa0cfd482b7bebbe4031"/></url>
				</image>
        			</item>

		
			<item>
				<title>MRBL: Next-Generation Gene Therapy for Molecular Skin Rejuvenation</title>
				<link>https://wyss.stage.a17.io/technology/mrbl-next-generation-gene-therapy-for-molecular-skin-rejuvenation/</link>
        <pubDate>Sat, 13 Mar 2021 04:40:00 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Skin]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=27773</guid>
                                                <content:encoded><![CDATA[<p>The skin is the largest organ in the body, and carries out multiple vital functions, including protective barrier functions against the loss of moisture and mechanical, UV and other injuries, immune defense functions, as well as sensory functions. For maintaining its integrity and multifaceted performances, skin relies on a range of different cell types that compose and support its layered&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/mrbl-next-generation-gene-therapy-for-molecular-skin-rejuvenation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/mrbl-next-generation-gene-therapy-for-molecular-skin-rejuvenation/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/03/09114207/CS_New_ListingImage72dpi.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=133fd337d6de5b047a72e3958e1a37b3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Improving Canine Healthspan</title>
				<link>https://wyss.stage.a17.io/media-post/improving-canine-healthspan/</link>
        <pubDate>Thu, 06 Feb 2020 16:21:59 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=23449</guid>
                                                <content:encoded><![CDATA[<p>A Wyss Institute technology that can treat multiple age&#x2d;related diseases is now being developed by Rejuvenate Bio into a treatment for mitral valve disease and other deadly conditions in dogs, with the goal of helping man&rsquo;s best friend live longer, healthier lives. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/improving-canine-healthspan/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/improving-canine-healthspan/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/02/06112026/THUMBNAIL_Dog-Age-Reversal_No-Text.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7c7c7014e604a8c42aea4efe41081cd0"/></url>
				</image>
        			</item>

		
			<item>
				<title>Rejuvenate Bio launches to help dogs live longer, healthier lives</title>
				<link>https://wyss.stage.a17.io/news/rejuvenate-bio-launches-to-help-dogs-live-longer-healthier-lives/</link>
        <pubDate>Thu, 06 Feb 2020 15:57:29 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=23423</guid>
                            <description>Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology Development to commercialize a gene therapy technology developed at the Wyss Institute and Harvard Medical School (HMS) to prevent and treat several age&#x2d;related diseases&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/rejuvenate-bio-launches-to-help-dogs-live-longer-healthier-lives/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/rejuvenate-bio-launches-to-help-dogs-live-longer-healthier-lives/</link>
          <title>Noah Davidsohn, CTO of Rejuvenate Bio and former Wyss Institute Research Scientist, was inspired by his German Shepherd, Bear, to develop a gene therapy that can help dogs live healthier lives. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/02/05120358/Canine-Healthspan-Noah-and-Bear-6670.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d10b1e20f314d426b801e260ddc6a58f"/></url>
				</image>
        			</item>

			</channel>
</rss>
